5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.96▲ | 3.89▲ | 3.89▲ | 4.28▼ | 4.56▼ |
MA10 | 3.92▲ | 3.87▲ | 4.00▼ | 4.51▼ | 5.75▼ |
MA20 | 3.88▲ | 4.02▼ | 4.19▼ | 4.62▼ | 8.52▼ |
MA50 | 3.95▲ | 4.25▼ | 4.42▼ | 6.14▼ | 13.90▼ |
MA100 | 4.18▼ | 4.50▼ | 4.40▼ | 9.06▼ | N/A |
MA200 | 4.29▼ | 4.48▼ | 5.53▼ | 13.42▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.026▲ | 0.007▲ | -0.024▼ | 0.049▲ | -0.250▼ |
RSI | 64.241▲ | 43.345▼ | 35.822▼ | 29.917▼ | 23.760▼ |
STOCH | 99.333▲ | 50.369 | 26.648 | 32.057 | 10.907▼ |
WILL %R | -3.226▲ | -41.758 | -64.667 | -82.903▼ | -96.492▼ |
CCI | 124.177▲ | 27.645 | -45.061 | -123.972▼ | -127.704▼ |
Monday, April 28, 2025 01:05 PM
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation ...
|
Monday, April 28, 2025 01:05 PM
SAN DIEGO--(BUSINESS WIRE)-- Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the ...
|
Wednesday, April 23, 2025 05:00 PM
Contineum Therapeutics’ peers have higher revenue and earnings than Contineum Therapeutics. Contineum Therapeutics is trading at a higher price-to-earnings ratio than its peers, indicating that ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 4.10 | 4.10 | 3.705 | 3.97 | 132,517 |
30/04/25 | 4.43 | 4.43 | 4.10 | 4.11 | 46,693 |
29/04/25 | 4.59 | 4.59 | 4.26 | 4.42 | 35,524 |
28/04/25 | 4.3315 | 4.51 | 4.31 | 4.50 | 49,545 |
25/04/25 | 4.52 | 4.61 | 4.355 | 4.41 | 47,542 |
24/04/25 | 4.80 | 4.80 | 4.47 | 4.52 | 57,901 |
23/04/25 | 5.09 | 5.25 | 4.72 | 4.74 | 52,200 |
22/04/25 | 5.00 | 5.255 | 4.85 | 4.90 | 63,000 |
21/04/25 | 4.61 | 5.00 | 4.345 | 4.95 | 153,600 |
17/04/25 | 4.37 | 4.88 | 4.30 | 4.62 | 139,500 |
|
|
||||
|
|
||||
|
|